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We have previously reported that erythrocyte phos- 
phofructokinase (PFK) was inhibited by 2,3-DPG 
[1,2]. In a recent letter, Staal and Koster [3] wrote 
that our results were in error. In the meanwhile, the 
prior observations of Busch and Boie [4], indicating 
that hemolysate PFK is inhibited by 2,3-DPG have 
come to our attention. Our findings regarding inhibi- 
tion of PFK by 2,3-DPG have also now been confirm- 
ed by Ponce et al. [5 1, using partially purified enzyme 
and by Tarui [6], using purified enzyme. It is quite 
clear that 2,3-DPG does inhibit PFK. 
Staal and Koster suggested that our findings were 
due to hydrolysis of 2,3-DPG by 2,3-DPG phosphatase 
to form 3-PGA which then resulted in oxidation of 
NADH through the phosphoglycerate kinase and 
glyceraldehyde phosphate dehydrogenase steps. Their 
interpretations are erroneous in several respects: 
1. The 2,3-DPG phosphatase reaction occurs at 
such a slow rate that we have been unable to measure 
it using the proposed reaction scheme. The activity of 
this enzyme is of the order of 12 milliunits per gram 
hemoglobin [7]; this is l/lOOth of the rate of the 
phosphofructokinase reaction with which they pro- 
pose it interferes. 
2. The magnesium and ATP dependent reaction to 
which Dr. Staal and Koster refer is observed only 
when commercial 2,3-DPG preparations contaminated 
with 3-phosphoglyceric acid (3-PGA) are used. Such 
contamination unfortunately seems to be present very 
frequently. For example, enzymatic assays of several 
lots of 2,3-DPG in our laboratory recently revealed 
that Sigma Lot No. 1100-0830 contained 4.35% 3- 
PGA while Boehringer Lot No. 7470416 contained 
3.69% and lot 7332316 4.55% 3-PGA on a molar 
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basis. Not all commercial 2,3-DPG is aS heavily con- 
taminated with 3-PGA. Boehringer Lot No. 7200215 
was found to contain very little (.03 1%) 3-PGA, and 
lot 7412117 only 0.07% PGA. We have been able to 
prepare 2,3-DPG which contains <O.Ol% 3-PGA by 
absorbing contaminated commercial 2,3-DPG on a 
Dowex 1 -formate column and eluting the 3-PGA with 
2 N ammonium formate-formic acid buffer, pH 3.0 
[8]. The 2,3-DPG can be eluted with 5 N ammonium 
formate, the ammonium ion removed on a Dowex 
50 column and the formic acid extracted with ether. 
It is best to avoid lyophilization of such purified 
2,3-DPG because there is a tendency for some of it to 
decompose to 3-PGA in the process. Using these pure 
preparations, the ATP and magnesium dependent rate 
to which Doctors Staal and Koster refer is not found. 
But inhibition of PFK occurs nonetheltss. It is clear 
that studies of 2,3-DPG inhibition of PFK in crude 
hemolysates must be carried out using 2,3-DPG which 
is quite free of 3-PGA. 
The inhibition by 2,3-DPG of PFK which we have 
observed in crude hemolysates, and others have ob- 
served with purified enzyme, is clearly not due to the 
side reaction proposed by Staal and Koster. Why then, 
are they unable to find an inhibitory effect? It is axi- 
omatic that it is essential to use the same techniques 
in attempting to reproduce another investigator’s 
findings. The inability of Staal and Koster to demon- 
strate inhibition of PFK by 2,3-DPG can be attributed 
to two factors. First of all, the inhibition of PFK bjr 
2,3-DPG is competitive with fructose 6-phosphate 
(F6-P) Although Staal and Koster state that they have 
varied the concentration of F6-P, the concentration 
given in their table is too high for meaningful inhibi- 
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tion to be observed. Indeed, using this concentration 
we were not able to detect significant degrees of inhi- 
bition of PFK by 2,3-DPG [2]. Secondly, the concen- 
tration of some of the reagents they used are signifi- 
cantly different from those which we reported. Of 
special importance is the fact that they employ a 300 
mM Tris-HCl buffer, six times the concentration 
which we use [9]. We find that this concentration of 
Tris-chloride is inhibitory to the enzyme in our assay 
system, and that the inhibition of PFK which is read- 
ily observed at low F6-P levels at a 50 mM Tris-HCl 
concentration is much less apparent at 300 mM Tris- 
HCl. For example, using our assay system with a 
F6-P concentration of 100 PM and 50 mM Tris buffer, 
5.38 U of PFK/gm Hb were found without 2,3-DPG 
and only 0.44 U with 5 mM 2,3-DPG (92% inhibi- 
tion). When the same hemolysate was assayed with 
300 mM Tris buffer the values obtained were 3.45 U 
and 2.83 U respectively (only 18% inhibition). It is 
likely that the bonds between 2,3-DPG and PFK are 
disrupted by high ionic strength; NaCl has a similar 
effect as Tris-HCl. 
In conclusion, there appears to be no question that 
PFK is inhibited by 2,3-DPG. Staal and Koster have 
been misled by the use of impure commercial prepa- 
rations of 2,3-DPG and by inadvertent use of assay 
conditions which are unsuitable for the demonstra- 
tion of this inhibitory effect. 
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